Notifying Changes To Marketed Devices In Singapore Becomes Easier
This article was originally published in Clinica
Executive Summary
Singapore's Health Sciences Authority has adopted a revised policy that makes it easier for medical device companies to notify the agency of any changes they make concerning a marketed device. The revised policy, issued in the form of an updated guidance, applies to "change notification" applications submitted by companies as of Dec. 1, when the policy came into effect.
You may also be interested in...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.